Iovance Biotherapeutics (IOVA) Insider Trading & Ownership $7.38 +0.16 (+2.22%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Iovance Biotherapeutics (NASDAQ:IOVA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.10%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$2.29 MNumber OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$503,000.00 Get IOVA Insider Trade Alerts Want to know when executives and insiders are buying or selling Iovance Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IOVA Insider Buying and Selling by Quarter Ad Weiss RatingsNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. Iovance Biotherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/12/2024Ryan D MaynardDirectorSell50,000$10.06$503,000.00 2/20/2024Merrill A McpeakDirectorBuy250,000$9.15$2,287,500.00 (Data available from 1/1/2013 forward) IOVA Insider Trading Activity - Frequently Asked Questions Who is on Iovance Biotherapeutics's Insider Roster? The list of insiders at Iovance Biotherapeutics includes Frederick G Vogt, Iain D Dukes, Merrill A Mcpeak, Ryan D Maynard, and Wayne P Rothbaum. Learn more on insiders at IOVA. What percentage of Iovance Biotherapeutics stock is owned by insiders? 12.10% of Iovance Biotherapeutics stock is owned by insiders. Learn more on IOVA's insider holdings. Which Iovance Biotherapeutics insiders have been buying company stock? The following insiders have purchased IOVA shares in the last 24 months: Merrill A Mcpeak ($2,343,100.00), and Wayne P Rothbaum ($26,500,000.00). How much insider buying is happening at Iovance Biotherapeutics? Insiders have purchased a total of 5,260,000 IOVA shares in the last 24 months for a total of $28,843,100.00 bought. Which Iovance Biotherapeutics insiders have been selling company stock? The following insider sold IOVA shares in the last 24 months: Ryan D Maynard ($503,000.00). How much insider selling is happening at Iovance Biotherapeutics? Insiders have sold a total of 50,000 Iovance Biotherapeutics shares in the last 24 months for a total of $503,000.00 sold. Iovance Biotherapeutics Key ExecutivesDr. Frederick G. Vogt Esq. (Age 50)J.D., Ph.D., Interim CEO, President, General Counsel & Corporate Secretary Compensation: $1.39MMr. Jean-Marc Bellemin M.B.A. (Age 51)CFO, Principal Accounting Officer & Treasurer Compensation: $932.2kDr. Igor P. Bilinsky (Age 51)Chief Operating Officer Compensation: $932.2kDr. Friedrich Graf Finckenstein M.D. (Age 57)Chief Medical Officer Compensation: $1.06MMs. Sara PellegrinoVice President of Investor Relations & Public RelationsMs. Tracy WintonSenior Vice President of Human ResourcesMr. Howard B. Johnson M.B.A. (Age 64)Chief Business Officer Mr. James Ziegler M.B.A.Executive Vice President of CommercialDr. Raj K. Puri M.D.Ph.D., Executive VP of Regulatory Strategy & Translational MedicineMr. Brian Shew M.B.A.Senior VP & Head of Digital and Information Technology More Insider Trading Tools from MarketBeat Related Companies Intra-Cellular Therapies Insider Buying Roivant Sciences Insider Buying Revolution Medicines Insider Buying Lantheus Insider Buying Nuvalent Insider Buying Blueprint Medicines Insider Buying Elanco Animal Health Insider Buying Cytokinetics Insider Buying TG Therapeutics Insider Buying Viking Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:IOVA) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iovance Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Iovance Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
